Please check your internet connection and try again.
# IV Dexamethasone
## Overview
Dexamethasone is a potent synthetic glucocorticoid with anti-inflammatory and immunosuppressive effects.
## Primary Indications
* Allergic states
* Dermatologic diseases
* Endocrine disorders
* Gastrointestinal diseases
* Hematologic disorders
* Neoplastic conditions (adjunct therapy)
* Nervous system conditions (e.g., cerebral edema)
* Ophthalmic diseases
* Organ transplantation (immunosuppression)
* Rheumatic disorders
* Respiratory diseases
* Rheumatic disorders
* Septic shock (adjunct therapy)
## Adult Dosing
Dosing is highly variable and dependent on the specific indication and severity of the condition. Common starting doses range from **4 mg to 24 mg IV daily**, often divided every 6 to 12 hours or given as a single daily dose. Higher doses may be used for specific oncologic indications or severe inflammatory states. Maximum daily dose is generally not strictly defined but typically does not exceed 96 mg in most standard indications. Specific protocols should be followed for conditions like cerebral edema or septic shock.
## Pediatric Dosing
Dosing in children is also highly variable and typically based on weight or body surface area. Commonly used doses range from **0.15 mg/kg/day to 0.4 mg/kg/day**, divided every 6 to 12 hours. For specific indications like croup, a single dose of **0.15 mg/kg to 0.6 mg/kg** is often used. Local protocols should be consulted.
## Dose Adjustments
No dose adjustment is typically required for hepatic or renal impairment, as dexamethasone is metabolized in the liver and excreted by the kidneys but generally does not accumulate to a degree requiring dose reduction in standard practice. However, prolonged use or higher doses can lead to significant side effects.
## Contraindications
* Systemic fungal infections
* Known hypersensitivity to dexamethasone or other components of the formulation
## Adverse Effects
Common adverse effects include hyperglycemia, insomnia, mood changes (euphoria, irritability), increased appetite, fluid retention, and increased risk of infection. Long-term use can lead to adrenal suppression, Cushingoid appearance, osteoporosis, peptic ulceration, myopathy, and growth retardation in children.
## Key Drug Interactions
* **CYP3A4 inducers** (e.g., rifampin, phenytoin, carbamazepine): May increase dexamethasone metabolism, decreasing efficacy.
* **CYP3A4 inhibitors** (e.g., ketoconazole, itraconazole): May decrease dexamethasone metabolism, increasing potential toxicity.
* **Antidiabetics** (e.g., insulin, oral hypoglycemics): Dexamethasone can antagonize their effects, leading to hyperglycemia.
* **Diuretics** (e.g., thiazides, loop diuretics): Increased risk of hypokalemia.
* **Vaccines** (live attenuated): Increased risk of disseminated infection.
## Monitoring
* Blood glucose levels, especially in diabetic patients or with prolonged use.
* Signs and symptoms of infection.
* Electrolytes (e.g., potassium), particularly with concomitant diuretic use.
* Growth and development in pediatric patients with long-term therapy.
* Signs of adrenal suppression (tapering dose is crucial).
## Clinical Pearls
* IV dexamethasone is significantly more potent than hydrocortisone and has minimal mineralocorticoid activity.
* For conditions requiring rapid onset, IV administration is appropriate.
* Abrupt discontinuation after prolonged use can precipitate adrenal insufficiency. Tapering of the dose is essential.
* Use with caution in patients with hypertension, congestive heart failure, diabetes mellitus, glaucoma, and seizure disorders.
***
*Disclaimer: This information is intended for clinical professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date information before making any treatment decisions.*
